The combination of PET and MR in one imaging device has certain advantages over conventional imaging modalities. These include: no additional radiation dose from the MR, superior soft tissue contrast and a multitude of tracers for PET. Certain technical challenges exist when designing a PET/MR system. On the one hand these stem from the presence of the strong MR magnetic field and the addition of PET components to the MR system. Different approaches are presented to overcome these technical obstacles ranging from long optical fibers to systems that use semiconductor light detectors for photon counting. The applications of combined PET/MR are profound in the field of oncology and allow imaging of the four main processes in cancer formation: apoptosis resistance, angiogenesis, proliferation and metastasis. PET/MR has also many clinical and research applications in neurology and cardiology. Alternative techniques such as image fusion, hyperpolarized imaging, 17 O imaging and whole body diffusion are discussed in respect to their relevance regarding PET/MR. Simultaneous multifunctional and anatomical imaging using PET/MR has a great potential to impact biomedical imaging in research and clinic.
Introduction

Why Combine PET and MR?
Medical imaging is about to change from stand-alone techniques towards multimodality imaging. This is mainly reflected by the combination of imaging methods Technology in Cancer Research & Treatment, Volume 9, Number 1, February 2010 providing functional parameters and additional spatial information. Therefore a specific metabolic signal from a molecular imaging modality such as positron emission tomography (PET) is acquired and combined with the anatomical information offered by other methods such as computed tomography (CT) or magnetic resonance (MR) imaging.
PET detects radiation from radioactive labeled biomarkers and offers a sensitivity in the picomolar range (1) . The injected small amounts of radioactive substances do not influence the biological system during the study. A huge spectrum of PET tracers is available for the examination of various metabolic processes. However, PET provides only a limited spatial resolution, especially when highly specific tracers are used. Examples are the 11 C-tracers raclopride and methylphenidate binding to D2 dopamine receptors and dopamine transporters in the very small striatum ( 1 mm) of the mouse brain. On the other hand, MR is based on the intrinsic spin properties of certain nuclei. Most MR studies employ the signals produced by the hydrogen proton spin. The sensitivity of MR is relatively small, in the micromolar range (2), but the spatial resolution and the soft tissue contrast are superior. Therefore the combination of PET and MR offers highly complementary information.
PET/MR Versus PET/CT
The combination of PET with CT in a single machinetermed PET/CT -is a very successful imaging approach matured to a routine clinical diagnostic tool over the last few years. Nowadays, the majority of the distributed PET scanners are combined PET/CTs (3) . However PET/CT has also some limitations.
Radiation dose is certainly a concern in PET/CT imaging, especially in children that are more radiosensitive for carcinogenesis than adults due to their higher cell division rate (4). The radiation exposures differ between the CT and PET scan. A study by Zhang et al., evaluated the dosimetry of 248 pediatric PET/CT scans and found an effective dose of 20.3 mSv for the CT and 4.6 mSv for the PET scan (5) . Depending on the CT study protocol and the PET tracer administered, only one quarter of the total radiation of a PET/CT exam results from the PET part, however more then 3 quarters from the CT. Not only human beings are susceptible to increased radiation doses. In small animal imaging radiation dose is a critical concern. Especially for cancer treatment studies it is important that the response to a certain anticancer-treatment can be attributed to the drug and not potentially to a hidden therapy effect caused by the CT irradiation. One has to be aware of these effects, especially for serial imaging studies in small animals (6) . In contrast to CT, MR does not include any ionizing radiation. Recently, there have been some objections on the synergistic effects of electrical and magnetic fields from the MR and the ionizing radiation resulting from the PET tracers (7) . However it is not very likely that these effects will be stronger than the radiation damages caused by a CT exam, since both PET as well as MR has been used in clinical diagnosis for years without triggering serious additional safety concerns. Therefore combined PET/MR imaging is favorable in terms of radiation dose compared to PET/CT.
Another important feature of in vivo imaging is soft tissue visualization. MR is known to excel with its variety of different contrast weightings over the capabilities of CT in determining different soft tissue structures. This is especially important in the field of small animal imaging, where often the application of contrast agents is problematic (8). An example of PET/CT versus PET/MR small animal imaging is shown in Figure 1 . A mouse was injected with a [ 18 F] fluoro-2-deoxy-D-glucose (FDG) tracer for the evaluation of the glucose metabolism. The non-contrast enhanced CT shows only roughly the outline of the animal as well as the subcutaneous tumor. Only the bones show a superior contrast. Yielding a CT equivalent contrast would require the injection of about 300 µL iodine-based contrast agent in a mouse with a blood volume of approximately 2.5 mL. The corresponding MR image in figure 1 highlights an excellent soft tissue contrast, which allows a differentiation of the tumor tissues as well as the abdominal organs (e.g., kidneys and spleen). It is evident that MR can improve the diagnostic accuracy and allows e.g., a differentiation between necrotic and vital tumor tissue. These data can then be matched with areas of low and high tracer uptake in the tumor. Studies comparing whole body PET/CT with whole body MR (wb-MR) disclosed, that PET/ CT is superior in lymph node screening, whereas wb-MR is highly sensitive in detecting distant metastasis (9, 10). Not only the field of oncology profits from the soft tissue contrast offered by MR, also neurology applications need the anatomical as well as functional imaging capabilities provided by PET/MR. Like in PET/CT, PET/MR allows a perfect co-registration of the PET and MR image data (11). This offers the possibility to use MR-derived anatomical landmarks to interpret the functional data obtained from the PET images. However, PET/CT co-registration has certain shortcomings especially in the abdomen and thorax due to the sequential nature of the data acquisition. Even dedicated breathing protocols in patient studies cannot avoid misregistrations between PET and CT (12) . PET/MR machines can bypass this disadvantage with a simultaneous data acquisition. Therefore movement artifacts are less pronounced by simultaneous PET/MR acquisitions.
the regular acquisition. These techniques can be applied to track the motion of the patient in real time (13). This motion information can then be either fed directly, as an online signal, into the PET data stream and correct the acquired data in real time in the line of response (LOR) space -or a retrospective motion correction can be performed in the imaging space of the PET data. Fast navigator sequences that allow tracking of patient motion have been implemented mainly for diffusion weighted as well as functional imaging based on echo planar imaging (EPI) and fast low angle shot (FLASH) sequences (14). These navigator scans are relatively fast (in the order of a few milliseconds), but they need to be added to the regular imaging sequence and require often longer prescan protocols (15). It is currently under discussion whether these motion correction paradigms can be added to every routine MR sequence, especially those with longer acquisition times (e.g., spin echo (SE) sequences).
The variety of tissue contrasts delivered from the MR system can also be used to aid and correct the PET image data. Due to the limited spatial resolution, quantitative PET measurements of glucose metabolism or neuroreceptor binding are impacted by the so-called partial volume effect. The observed PET images are a convolution of the scanner point spread function with the tracer distribution within the tissue compartments. If a support function is defined, which describes the dimension and geometry of the target tissue, the real tracer concentration at a given position can be calculated. This support function can be derived from MR image data and is usually gained by a voxel based segmentation approach. A study has shown that especially in aging and neurodegenerative diseases, where the cortical signal is diluted by enlarged cerebro spinal fluid (CSF) spaces and changes in the white matter volume, a MR based partial volume correction for PET is beneficial (16). Baete et al. used a MR anatomy based reconstruction of the PET images in [ 18 F]FDG PET, which significantly improved the detection accuracy of hypometabolic regions (17). As a step further one could imagine an augmentation of the PET image reconstruction by the MR imaging data. These MR aided PET reconstruction methods try to increase the spatial resolution of the PET image as well as to yield a better quantification accuracy (18).
Beside anatomical information, MR can also extract various functional parameters. In a PET/MR system one could complement the functional data obtained from PET by e.g., functional MR imaging (fMRI). This does not only cover activation studies dealing with the blood oxygen level dependent (BOLD) contrast but also other advanced MR methods such as diffusion, perfusion and spectroscopy. Functional MR information can be used to aid PET data modeling. It seems to be feasible that perfusion information is extracted . It is obvious that the PET image alone does not yield enough information for an anatomical interpretation. In the CT image only a coarse outline of the anatomical structures are visible. Especially in the tumor region, the differentiation between tumor tissue and surrounding areas is not possible. In contrast, the MR image shows profound details. Kidneys and spleen can be clearly identified. Surrounding connective tissue is embedding the tumor (second row right). The PET/CT fusion does not pin down the exact tumor location, however this can be achieved with the PET/MR fusion (third row right).
Technology in Cancer Research & Treatment, Volume 9, Number 1, February 2010 from MR images and then used for PET receptor modeling. Further applications that result from simultaneous acquisition of fMRI with PET will be discussed in more detail in the later section of this review.
The ability to acquire simultaneous PET and MR data, which is addressed in most PET/MR realizations, saves acquisition time. This results in human PET/MR in an increased patient throughput and improved patient comfort, since the time inside the scanner is reduced compared to a sequential imaging acquisition. For small animal PET/MR the animal throughput is also increased and, even more important, the anesthesia time for the animals can be substantially reduced. A shorter time under anesthesia is in general more beneficial for animal well being and the experimental conditions.
PET/MR Technology
Given the numerous advantages of combined PET/MR the question arises, why those two imaging modalities have not been combined earlier. First patent applications for combined PET/MR have been already filed in 1990, before even the first PET/CT systems became commercially available (19).
Technical Challenges
Combining PET and MR is a technically challenging endeavor. There are mutual interferences between these two technologies. The interferences from the MR on the PET origin mainly from the strong static magnetic field of the MR scanner, as well as radio frequency (RF) interferences and induced currents from the switching of the gradient system. The photomultiplier tubes (PMTs), which are used in common PET systems, cannot operate in the vicinity of strong magnetic fields. The PMTs convert and amplify the light signal, obtained from the scintillation crystals. To accomplish this effect, the incident photons are converted to electrons at the photo cathode being amplified by a dynode system. The electron path between these dynodes is however distorted as soon as it is exposed to a magnetic field. On the other hand, there is a concern, that the insertion of a PET detector inside a MR scanner can distort the main magnetic field (B 0 ) homogeneity of the MR machine. Eddy currents can be induced from the gradient system of the MR in conducting structures of the PET detector and housing, resulting in MR image artifacts. RF interferences can result from the PET electronics and lead to an increased noise level or artifacts in the MR. For a combined PET/MR system allowing simultaneous data acquisition, the PET system has to be placed inside the MR system. As a consequence the open MR bore is reduced inside by the insertion of the PET components. Moreover, environmental factors like temperature or temporal stability of both scanners need to be maintained in a combined PET/MR system.
PET/MR Systems
To overcome these technological problems, there have been various PET/MR design and construction approaches developed over the last years. They are schematically shown in figure 2 and will be discussed in the following sections.
Separated PET and MR Scanners
The simplest conception to combine PET and MR is the use of two stand-alone imaging systems which are linked by a common patient handling system allowing a transfer of the patient with minimal movements between the two modalities ( Figure 2a ). If the two systems are installed independently in two rooms, PET/MR examinations are feasible without a redesign of the individual imaging system. A group in Korea has realized such a PET/MR. They are using a 7 T MR tomograph and a high resolution PET system. The patient is transferred between the systems by a special designed shuttle table (20). One step further, the PET and MR system can be installed close to each other in the same scanner room. Such an approach requires at least some shielding or optimization of the PET light detectors. One has to be aware that the image acquisitions in such a system are not isochronous. Strictly speaking, the correlation of functional data obtained in such sequential acquisitions has limitations due to changing physiological parameters between the two modalities (e.g., temperature). Additionally, as already mentioned, scanning and anesthesia time reduction or MR based PET motion correction are limited. The use of only one patient table for the PET and MR study can avoid repositioning. This is a benefit for image co-registration. Furthermore, most PET tracers require a certain uptake time. For this purpose, the MR scan time could be used as uptake time before the patient is then scanned in the PET machine. Depending on imaging findings, a rescan in the MR of certain regions could be performed. For studies that aim on combining functional information from the PET with anatomical information from the MR a sequential imaging approach might be suitable.
Long Light Fiber PET/MR Systems
An early PET/MR approach used long optical fibers (2 m or longer) to transfer the light from the scintillation crystals out of the magnet (Figure 2b) . Usually, the photomultiplier tubes are placed outside the magnet in a shielded box. Initially, this design was employed to measure the reduced positron range inside a magnetic field (21, 22) . In the mid 1990s, Paul Marsden and Simon Cherry acquired the first PET/MR images with systems using long optical fibers (23, 24) . At this time, it was already possible to study certain organs e.g., isolated perfused mouse hearts using such a system (25) . Basic studies of the MR and PET compatibility showed that no major interferences arise from each other (26).
However, long light fibers are associated with problems in PET signal processing. Due to the fiber's length, only a portion of the initial scintillation light reaches the photomultiplier tubes. Depending on the material, length and design of the optical fibers, the loss in signal can be more than 60%. Furthermore the shape of the light pulse is distorted, since the optical fibers lead to a dispersion of the signal and pulse width spreading. In general, the performance of a system using long optical fibers to transfer the scintillation light, is reduced compared to systems without fibers. Additionally, a substantial amount of space is required for fiber installation in the magnet bore, as they have to be connected to every crystal in the PET ring. These space issues lead to a limited expandability of PET field of view (FOV). Nevertheless, some PET/MR systems use optical fibers (27) (28) (29) .
Split Magnet PET/MR Systems
The use of a split magnet ( Figure 2c ) is another way to combine PET and MR being pursued by a group from Cambridge (13). In this approach, the PET detector undergoes only a minor adaption and remains similar to conventional PET detectors based on PMTs as they are used in commercial small animal PET scanners. However, to make simultaneous PET/MR measurements feasible, the MR scanner has to be significantly modified. The system uses a custom-made 1 T magnet with a slit opening of 80 mm. This allows the accommodation of a multi-ring PET system based on a commercially available animal PET detector (30). The PET ring consists of 96 scintillation detector blocks, arranged in 4 axial rings, yielding a diameter of 14.7 cm and an axial extent of 7.6 cm. The detectors use 12 12 arrays of lutetium oxyorthosilicate (LSO) crystals with single crystal dimensions of 1.52 1.52 10 mm 3 . These crystals are coupled via 110 cm long, in radial direction arranged optical fiber bundles to position sensitive photomultiplier tubes (PS-PMTs). The PS-PMTs are arranged outside of the magnet in a steal shielding. This way the ambient magnetic field at the PMT position is reduced to 1 mT. The system can be operated without detectable interference between the two modalities (31). Such a PET/MR device needs a dedicated set of gradient and shim coils with a split design as well (32). The RF coil for the MR signal generation is hosted inside the gradient coil. Compared to a long optical fiber system, the MR gantry is not occupied by fibers as they are led out in radial and not in axial direction, and the fiber length in this setting is 5 times shorter. But even with such relatively short optical fibers, light losses are on the order of 60% (10 cm vs. 120 cm fiber length). The timing resolution is degraded from 2.6 ns to 3.6 ns (10 cm vs. 120 cm fiber length). However, the spatial resolution of 1.6 mm is not impacted (33). Moreover, the magnetic field strength of such split magnet systems is limited by magnet design considerations to about 1 T. Therefore, especially for small animal studies the MR signal to noise ratio (SNR) obtained by such a system might not be sufficient for all study protocols, especially when functional imaging such as BOLD is applied.
Alternatives to PMTs
As already noted, the use of long optical fibers requires usually an area with a low magnetic flux density for the highly magnetic field sensitive PMTs. On the other hand, semiconductor based light detectors can replace the PMTs (Figure 2 d-f). Mainly two different types of semiconductor light detectors are implemented in PET/MR scanners. Avalanche Photo Diodes (APDs) (based on silicon semiconductors) are compact devices compared to the bulky PMTs ( Figure 3 ). APDs can be operated without interferences in high magnetic fields (34) . APDs have been successfully tested in B 0 fields up to 9.4 T (35). However, the inherent gain of APDs is relatively low (around 100) compared to PMTs. Therefore they usually require additional amplifier electronics. The inherent amplification of APDs is sensitive to temperature fluctuations. This necessitates a tight temperature stabilization for their proper operation (36). Another semiconductor light detector type are Geiger-mode APDs (G-APDs, silicon-photomultipliers (Si-PMs) or solid state photomultipliers (SSPMs)). These light detectors consist of a matrix with identical microcells. Each cell is operated as an individual photon counter in Geiger-mode. G-APDs compared to APDs provide a higher intrinsic gain of up to 10 7 and a lower noise (37). Due to their high intrinsic gain, G-APDs can be operated without additional amplification stages in the vicinity of the diodes. In this way, a more compact PET/MR design is realizable. In addition, the timing resolution of G-APDs is very fast. This allows time of flight (TOF) PET measurements with these detectors in a human scanner setting (38).
Combination of Short Optical Fibers and Semiconductor Light Detectors
The group of Simon Cherry at the University of California, Davis, has used semiconductor light detectors in combination with short optical fibers to build a PET/MR system (Figure 2d ). LSO scintillation crystals (64 crystals in 8 8 arrays, each crystal measuring 1.43 1.43 6 mm 3 ) were coupled via approximately 10 cm long optical fibers to position sensitive APDs. The signal from the APDs was further amplified and processed to generate PET images. A RF coil for MR signal transmission and reception was placed inside the PET insert. The combined PET/MR FOV of this system is 12 mm in axial direction and 35 mm in transversal direction. The position sensitive APDs were cooled down to -5 to -10 °C. No deleterious interactions were detected between the two modalities (39, 40). The main reason for this design idea was to place the APDs as well as the sensitive amplifier electronics outside the MR field of view. This way the effects of these components on the MR system, such as B 0 homogeneity are reduced, but some RF based MR interferences on the PET and vice versa are still possible. Again, the use of the short light fibers requires a substantial amount of space and the expansion of the axial field of view of this system is limited. Light loss, timing and energy resolution degradation due to the use of light fibers have already been mentioned before, but are minimized by the very short fibers used in this approach. 
PET/MR Systems that Couple the Light Detectors Directly to the Scintillation Crystals
To overcome the limitations of timing and energy resolution that are connected with the use of optical fibers for scintillation light transport our group has developed and built a PET-insert that directly couples the scintillation crystals to APDs (Figure 2e ). The PET ring consists of 10 detector cassettes, each with 12 12 LSO scintillators (crystal size: 1.6 1.6 4.5 mm 3 ). They are coupled with a small light guide to a 3 3 APD array. A RF coil for MR signal transmission and reception (TRX) is installed inside the PET-insert. The combined PET/MR FOV of this system is 19 mm in the axial direction, limited by the PET detector size, and 35 mm in the transversal direction, limited by the RF coil diameter. The APD signal is amplified and fed to the PET data collection electronics by coaxial cables. No substantial mutual interference between PET and MR was observed with this system (41). This PET insert is installed at the center of a commercial 7 T small animal MR scanner (Figure 4a ). Like in other systems, APDs require temperature stabilization. This is realized by air-cooling as well as temperature dependent regulation of the APD voltage. Since no optical fibers are involved, the performance of an APD based PET system can compete with conventional PET systems. Furthermore, the system can be easily expanded in the axial direction by adding multiple APD and crystal detector rows.
The same design principles using, APDs, are also realized in the first human PET-insert that slip fits inside a 3 T clinical MR system (Figure 4b ) (42). They are coupled to a 12 12 LSO crystal matrix, with an individual crystal size of 2.5 2.5 20 mm 3 . A total of 32 circularly arranged detector cassettes, each with 6 LSO-APD block detectors, arranged in axial direction, form a PET ring. The FOV of this system is 19.2 cm in the axial direction and 35.5 cm in the transversal direction. First simultaneous human brain PET/MR images have been successfully acquired using this system (43, 44) . For MR imaging a TRX head coil is installed inside the PETinsert. The coil consists of two parts, an outer part that can be used as a stand-alone TRX coil and an additional inner coil. The inner coil part allows a 8 channel MR signal reception, which enables also parallel MR imaging technologies such as GRAPPA (45) and SENSE (46). The PET-insert can be installed in and removed from the MR scanner on a sliding device in less than 10 minutes.
PET/MR Systems that use Electro-Optical Coupling
A novel design approach was proposed by Olcott et al., from Stanford University (47) . The system uses solid state photomultipliers (SSPM) as light detectors (Figure 2f ). It has a proposed whole body capability with a FOV of 19.2 cm in axial direction and 60 cm in transversal direction. Due to the high intrinsic gain of the SSPM, the group couples the electrical output of the SSPM directly to the input of a vertical cavity surface emitting laser (VCSEL) diode. The diode converts the electrical input signal to an optical signal being transferred via multi-mode optical fibers to a photodiode receiver. This receiver is installed outside of the MR system. Subsequently, the electrical output of the receiver is then connected to a standard PET data acquisition system. When testing this approach with a 20 m long light fiber, no significant increase in the noise or a degradation of the detector SNR was found. In addition, the coincidence timing resolution was not significantly influence compared to a setup without light fibers. It is suggested that since only small DC voltages (-30V and -5V) and passive electrical components are required for operation of the SSPM and VCSEL, no RF shielding is needed for such a PET detector (48). The marked difference of this design versus the long optical fiber design is, that the light fibers are now used to transfer the PET signals available after an initial light detection and amplification. As a consequence, light losses and other adverse effects are pronounced to a much smaller extent or may even be negligible. The electro-optical coupling is simply acting as an optical wire. This design allows a great space extension of the insert. Multiplexing of the individual PET detector elements via the optical fiber is also a promising feature. However, it has to be shown that such a system can operate inside a MR bore without mutual interference and without any shielding.
Field Cycling PET/MR Systems
Besides the previously mentioned PET/MR systems, there are constructions switching off the magnetic field during PET data collection and turn it on again for the MR data acquisition (49). Since the data acquisitions are not simultaneous, such a system resembles in its abilities the approach shown in Figure 2a . In this setting the PET component can be centered in the MR FOV, which minimizes artifacts due to patient repositioning. Moreover, field cycling MR offers some interesting contrast parameters such as magnetic field dependent relaxation time data (50, 51) . First MR images obtained by such a system show a potential for improvement of SNR (52). Beside alterations in the PET system and a special MR technology that allows a high polarizing magnetic field and a low field for data acquisition (53), field cycling has some advanced design challenges. Moreover, the field strength of such systems is usually limited due to the fact that a relative fast on and off switch of the magnet needs to be performed. This in turn limits the SNR for certain MR studies, compared to conventional high field MR systems.
Imaging Modalities in Oncology
In the past decades, the basic knowledge about the biology of cancer has increased tremendously. It is now of general consensus that tumorigenesis involves a multi-step process including angiogenesis, apoptosis resistance, proliferation and invasiveness (54) ( Figure 5 ). Targeted therapies are more and more expanding and even replacing conventional cytotoxic chemotherapies. These emerging therapies take effect in a pathway-orientated fashion and therefore require new sophisticated imaging modalities and algorithms to monitor the disease course and the therapy response. Molecular imaging is already playing a key role in the evaluation and development of new drugs by accessing different pathways with novel biomarkers (55). We believe that PET/MR in preclinical and clinical applications will act in concert with the other diagnosis and therapy approaches and serve as a catalyst in this field. Our main efforts should be to exclude the patient as soon as possible from insufficient or incompatible therapies and guide him to the right therapy. In addition, we hope to accelerate drug development by multimodality imaging and make it more cost efficient. In the following sections the basic imaging modalities like CT, MR and PET/CT will be discussed in a clinical setting towards oncology. This background is important to understand the value of PET/MR.
Computed Tomography
Because of its high anatomical resolution, standardization and availability, computed tomography is without a doubt the number one imaging modality in oncology. However, recent reports question the appropriateness of criteria, such as World Health Organization (WHO) and Response Evaluation Criteria In Solid Tumors (RECIST), for response evaluation. While these assessments of tumor size are widely accepted for the evaluation of classic cytotoxic chemotherapies (56), targeted therapies like sorafenib (57) and bevacizumab (58) show no significant reduction in tumor size. But on the other hand these therapies have proven to prolong progression-free survival. This misinterpretation results mainly from necrosis and cavity formation that don't influence necessarily the lesion extent significantly. To overcome these limitations Choi et al., developed new response criteria for the evaluation of gastro-intestinal stromal tumors (GIST) treated with imatinib (59). For RECIST a partial response is defined as a 30% reduction of the sum of the largest diameters and progressive disease as an increase of 20%. For GIST it has been determined that the tumor density represented by Houndsfield Units (HU) is worth to include. A partial response is defined by a decrease of 10% or a decrease of 15% in HU. Progressive disease is defined by an increase of 10% and no decrease in tumor density. As conventional computed tomography provides no additional information on biochemistry and physiology new developments are focusing on dynamic contrast enhanced perfusion CT (60). This technique provides additional parameters like blood flow, blood volume, capillary permeability and microvessel density. Initial results are promising in the evaluation of angiogenesis, but further studies have to be added. Zhao et al., discuss in their review the potentials of tumor-volume measurements with volumetric CT (61). These protocols together with density and perfusion measurements will certainly improve the results of the post therapy monitoring studies and may be widely applicable. However, this approach covers only a small part of the tumorigenesis cycle ( Figure 5 ) e.g., angiogenesis. The essential discrimination between vital tumor, necrosis and post-operative scar remains an issue.
Magnetic Resonance Imaging
MR provides a better soft tissue contrast compared to CT and offers additional functional information like tumor perfusion (62), vascular permeability (63), blood volume and flow, extracellular space tortuosity (62) and somewhat hypoxia (64). Conventional cross-sectional modalities usually have limitations in the determination of the T stage in the TNM staging convention. Depending on the disease entity, MR has some advantages in the evaluation of the local extension compared to CT (65). Dynamic contrast enhanced MR (DCE-MR) is typically performed with low-molecularweight paramagnetic contrast agents (e.g., gadolinium) and reveals in the aberrant tumor vasculature a signal enhancement in T1-weighted sequences. Figure 6 exemplifies some of the imaging options offered by MR using different MR sequences in a mouse brain tumor model. This makes MR a valuable device to monitor anti-angiogenic therapies like bevacizumab in tumor-bearing small animals (66) and patients (67). One step further, it is possible to calculate parameters for tissue microvessel perfusion, permeability and extracellular extravascular leakage space to quantify the Figure 5 : The main four processes (apoptosis resistance, angiogenesis, proliferation and metastasis) involved in cancer development with some treatment and imaging options. Obviously, a single modality alone does not provide enough inside into the relevant tumor processes. Combined information from multiple modalities such as PET/MR can be either used to clarify a diagnosis by imaging relevant parameters e.g., for proliferation with PET and MR simultaneously, or to monitor multiple process parameters such as angiogenesis with MR and proliferation with PET.
Technology in Cancer Research & Treatment, Volume 9, Number 1, February 2010 changes during therapy (68). However, the different scanning protocols used in past studies alter the reproducibility and make general statements difficult. The options of MR don't stop here. Diffusion weighted MR imaging (DWI) is based on the thermal motion of water in biologic tissues, which is influenced by cell membranes and macromolecules (69). Especially in neoplasia with a high cellular density this motion is limited. In contrast, when a necrosis develops, the DWI signal increases due to swelling and lysis of the cells. A parameter for the quantification of the tissue diffusion is the so-called apparent diffusion coefficient (ADC). Patient studies have proven that DWI provides a better diagnostic accuracy, e.g., in therapy monitoring of advanced rectal cancer (70), compared with the standard MR imaging (first tow rows) . Moreover, the various contrast mechanisms can be exploited to track down further data about the tumor microenvironment. T1 and T2 maps deliver information about relaxation times (third row). Diffusion, magnetization transfer ratio (MTr) and finally arterial spin labeling (ASL) perfusion deliver supplementary data about the tumor state and its response to treatment. All this information is available in reasonable imaging time and with high spatial correlation by using a combined PET/MR device. The images above were acquired using the small animal PET insert as shown in Figure 4a. sequences. Additionally, MR is able to detect tissue metabolites by magnetic resonance spectroscopy (MRS). The nuclei of special nuclear isotopes, when exposed to a strong magnetic field, start to resonate at a specific frequency. These different frequencies present the chemical properties of the measured environment. In a clinical setting spectroscopy can provide important additional information for e.g., the discriminating between low-and high-grade tumors (71). This is based on the altered metabolism of choline in malignancies. Small animal models provide a fundament for further investigations in this field (72). Finally, new MR contrast probes like macromolecular contrast agents, targeted gadolinium and ultrasmall superparamagnetic iron oxide (USPIO) complexes are in the pipeline and it is exciting how they will chance the daily diagnostic routine (73, 74) .
PET/CT
A lot of reviews have already focused on the great potential of combined . Regarding the diagnostic management of non-small cell lung carcinoma [ 18 F]FDG-PET was found to be preferable to dynamic contrast-enhanced CT due to a higher specificity (80). However, the introduction of PET/CT improved sensitivity, specificity and diagnostic accuracy even more due to a better staging of the primary tumor. A treatment study with GIST patients and morphologybased response evaluation has already been quoted in the previous text. It could be shown that the [ 18 F]FDG-PET response which is linked to a decline in the proliferative and metabolic activity, arises much earlier than the anatomical response and is linked to a longer progression free survival (81). The list of highly specific PET tracers is exhaustless and constantly continued by research institutes and companies, as this field became an intensive area of research. All of them use the great advantages of PET technology in detection sensitivity, reproducibility, reliability and quantification accuracy (61).
PET/MR
From a financial consideration it is clear that this sophisticated technology will be more expensive in the beginning than PET/CT. But as for all imaging devices, as soon as the demand increases and the production processes become more standardized, prices will drop.
Recalling Figure 5 , it becomes obvious that MRI offers more options to evaluate the different processes involved in tumorigenesis than CT. The union with PET and its multitude of available tracers can potentiate this advantage even more. PET tracers can for instance be used to depict tumor proliferation as well as amino acid metabolism in combination with MR methods such as diffusion and perfusion imaging ( Figure 6 ). This raises hope that PET/MR can be a power-ful modality to learn more about the pathogenesis of cancer or other diseases. This new knowledge will improve imagebased prognosis of the patient's course, progression-free survival and therapy response.
Further Applications of PET/MR
Neurology Neurology is probably one of the fields in medical sciences that will tremendously profit from simultaneous PET/MR measurements. Especially in rapidly changing disease progression or non-repeatable functional processes, isochronous measurements of certain metabolic parameters can be essential. Exemplary applications for simultaneous PET/MR are stroke and epilepsy imaging. With [ 15 O]-PET measurements it is possible to identify brain tissues at risk in acute stroke using the cerebral metabolic rate of oxygen utilization (CMRO 2 ) and oxygen extraction fraction (OEF). This can be accompanied with DWI and DCE-MR measurements. DWI and perfusion data often reveal a mismatch and these areas do not reliably correspond to the elevated OEF areas in PET (82). These limitations of DWI and perfusion weighted MR may influence treatment decisions e.g., lysis (83). In focal epilepsy patients, an increase of glucose consumption is found during seizure (84). Between the seizure events a decrease in glucose metabolism can be measured with [ 18 F]FDG-PET (85, 86). PET/MR offers an exact co-registration of the areas with changed glucose metabolic rates and the anatomical MR images. This might provide necessary information for a treatment of the epileptic foci, e.g., with neurosurgery. In addition, PET/MR yields a multitude of information for the study of aging brain diseases e.g., Alzheimer´s disease. PET tracers such as the so-called Pittsburgh-Compound-B (PiB) can be used to monitor the amyloid aggregation (87). Another PET tracer, PK11195, can be applied to image inflammation (88). The glucose metabolism is decreased in Alzheimer´s disease patients, which again can be observed with [ 18 F]FDG-PET (89). MR allows to study Alzheimer´s disease with a multitude of methods, e.g., DWI with tractography (90), magnetization transfer (91), MR volumetry (92) or MR perfusion imaging (93), but at lower detection sensitivity and potentially at much later disease progression than with PET. Combining these imaging options enables a more precise diagnosis and, hopefully in future, a better therapy response monitoring. The study of neurotransmitters with PET is beneficial for the diagnosis and therapy control of Parkinson´s disease (94). Combining these tracer studies with MR methods such as arterial spin labeling or BOLD imaging, allows metabolism monitoring on multiple stages. In summary, PET/MR opens the possibility to cross-calibrate different parameters. Using simultaneous PET/MR data acquisition, many confounding parameters and changes in physiological parameters that might result from repositioning the patient are reduced. Cardiology Studies in cardiology are common in nuclear medicine. PET excels the visualization of perfusion (95), ischemia (96) and metabolism of the heart (97). On the other hand, it has its weaknesses in accessing cardiac function and volume as well as ejection fraction (EF) (98) where MR is superior to PET and CT. Coronary vessels can be better visualized in MR compared to PET, although CT remains still the superior modality. MR contrast agents can be used to visualize cardiac perfusion (99), but these contrast agents are rather unspecific and relatively high dosages are needed which might cause side effects like nephrogenic system fibrosis in patients with an impaired kidney function (100). In cardiology, PET can reveal specific molecular parameters such as perfusion, glucose or fatty acid metabolism. This is highly complementary with the highresolution structural information provided by MR.
Alternative Techniques
Discussing combined PET/MR it is also important to realize the shortcomings of this technology and discuss some alternatives. One major disadvantage of PET/MR is the high cost of the imaging devices. Combined PET/MR tries to merge two very expensive imaging modalities. Moreover PET imaging requires the use of radioactive tracers. They can either be produced on site requiring an expensive cyclotron unit and a radiochemistry or can be transported to the imaging facility. These transports are limited by the half-life of the radioactive isotopes. Therefore in many occasions only the transport of relatively long-life isotopes such as [ 18 F] is possible.
Image Fusion of Sequentially Obtained PET and MR Images
Image fusion is a frequently announced argument against simultaneous PET/MR. In this case PET and MR images are acquired sequentially and then fused after the examination. This approach might work well in the brain where automatic and also manual image fusion can be applied, however, for applications in the abdominal area this is cumbersome due to organ movement. Moreover, studies of multifunctional imaging processes with an exact alignment of PET with MR imaging are not possible with this sequential approach.
Hyperpolarized MR
Another alternative technique to PET/MR is hyperpolarized MR imaging. Hyperpolarized MR uses certain nuclei such as 3 He or 13 C. The distributions of the nuclei spins are changed from thermal equilibrium to a hyperpolarized state. This results in a strong increase (10,000 fold or more) in the MR signal delivered by such nuclei in MR spectroscopic or MR spectroscopic imaging experiments (101). Certain molecules can be labeled with the above-mentioned nuclei and then hyperpolarized. These allow the assessment of lactate, alanine and pyruvate metabolism e.g., in tumors (102). Using spectroscopic MR imaging techniques might enable to differentiate between bound and unbound molecules at the region of interest. PET in contrast, can only visualize the total tracer concentration, but not its metabolic state at the region of interest. However, hyperpolarized MR imaging has also its limitations. The hyperpolarized half live of the administered substances is relatively short (a few seconds to minutes). Therefore, only the rapid components of the metabolic activity can be monitored with fast imaging sequences. Moreover, the amount of administered substances is relatively high (in the order of milli-to micromolar concentrations) and it cannot be excluded that in some circumstances the biological system under study might be altered.
O Magnetic Resonance
MR imaging using 17 O is a technique that either uses injected 17 O-water, or inhaled 17 O to image perfusion or CMRO 2 . The nuclei 17 O can be either detected directly by using dedicated MR imaging equipment (transmitter, receiver, coils) or by an indirect approach using the influence of 17 O relaxation on the 1 H signal due to T2 relaxation processes or T1 spin lock techniques (103). However, 17 O-imaging approaches do not offer the great variability of PET tracers. Currently, the indirect 17 O approach seems not as capable in quantifying CMRO 2 as the direct 17 O approach using dedicated, but rather expensive MR equipment.
Whole Body Diffusion MR
Whole body MR diffusion images are often inverted to gain a similar look as [ 18 F]FDG-PET images (104). It is important to realize that diffusion and PET do not measure the same parameters. We believe these two techniques are more complimentary than redundant. Moreover, the inversion of diffusion images does not always deliver clear results that allow the identification of tumor metastases. A reliable diagnosis based on single whole body MR diffusion images has to be questioned as the ADC values of healthy tissues and of tumors are often overlapping (105).
The alternative techniques described in this section have their own respective advantages and disadvantages. It is important to realize that many of them can be combined with simultaneous PET/MR to even further enhance this multimodality imaging approach. This can help to further establish multiparametric imaging techniques or to gain much more detailed diagnostic information.
Conclusions
Combined PET/MR imaging offers several advantages over current combined techniques such as PET/CT or stand-alone PET and MR imaging. These advantages mainly stem from the superior soft tissue contrast of the MR and its functional imaging capabilities as well as the simultaneous nature of data acquisition enabled by most PET/MR approaches. Certainly, technical challenges exist when combining these two modalities. However, multiple approaches prove that these problems can be solved. PET/MR possesses a huge potential in the field of oncological imaging as well as neurology and cardiology. Alternative techniques do not offer the versatility of advanced PET/MR imaging. Currently mainly small animal studies and a couple of human PET/MR brain studies are performed. Much more applications, as well as the clinical value of PET/MR will be proved once these systems become more widespread and whole-body PET/MR scanners become available.
